Recently, some studies have reported a new index related to systemic inflammation (SI) and insulin resistance (IR), the C-reactive protein (CRP)-triglyceride-glucose index (CTI), which can predict the survival of patients with cancer and the poor prognosis of cancer patients with a high CTI (8). This evidence concerns the gene CRP and Insulin resistance.